Nomura Holdings Inc. increased its holdings in Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) by 18.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,262,445 shares of the medical equipment provider’s stock after acquiring an additional 198,111 shares during the period. Nomura Holdings Inc.’s holdings in Corindus Vascular Robotics were worth $1,077,000 at the end of the most recent reporting period.
Separately, Citadel Advisors LLC increased its position in Corindus Vascular Robotics by 205.4% in the 3rd quarter. Citadel Advisors LLC now owns 115,728 shares of the medical equipment provider’s stock worth $164,000 after purchasing an additional 77,829 shares during the last quarter.
Shares of CVRS stock opened at $1.98 on Friday. Corindus Vascular Robotics Inc has a fifty-two week low of $0.70 and a fifty-two week high of $2.01.
In related news, Director Louis A. Cannon acquired 573,798 shares of the stock in a transaction dated Tuesday, March 12th. The shares were acquired at an average price of $1.38 per share, with a total value of $791,841.24. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, major shareholder Hudson Executive Capital Lp acquired 2,899,391 shares of the stock in a transaction dated Tuesday, March 12th. The shares were bought at an average cost of $1.38 per share, for a total transaction of $4,001,159.58. The disclosure for this purchase can be found here.
COPYRIGHT VIOLATION WARNING: This news story was originally published by Week Herald and is owned by of Week Herald. If you are accessing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The correct version of this news story can be viewed at https://weekherald.com/2019/03/17/corindus-vascular-robotics-inc-cvrs-shares-bought-by-nomura-holdings-inc.html.
Corindus Vascular Robotics Profile
Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted precision vascular systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures.
Featured Article: Asset Allocation and Your Retirement
Want to see what other hedge funds are holding CVRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS).
Receive News & Ratings for Corindus Vascular Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics and related companies with MarketBeat.com's FREE daily email newsletter.